Citrullus colocynthis (L.) Schrad.: A Promising Pharmaceutical Resource for Multiple Diseases

• Published in: Molecules (Basel, Switzerland) Vol. 28; no. 17; p. 6221
• Main Authors: Cheng, Xiaotian, Qin, Minni, Chen, Rongrong, Jia, Yunxia, Zhu, Qing, Chen, Guangtong, Wang, Andong, Ling, Bai, Rong, Weiwei
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 24.08.2023; MDPI
• Subjects: antidiabetic effect; Antidiabetics; antitumor; Arthritis; Asthma; Cancer; Cell cycle; Citrullus colocynthis (L.) Schrad; Cucurbitaceae; Cytotoxicity; Diabetes; Flavonoids; Flowers & plants; Fruits; Inflammatory bowel disease; insecticide; Insecticides; Phytochemicals; Review; Seeds; Toxicity; Pakistan; Morocco; Tunisia; Sudan
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules28176221

Citrullus colocynthis (L.) Schrad. (Cucurbitaceae) is widely distributed in the desert areas of the world. The fruit bodies of C. colocynthis are recognized for their wide range of nutraceutical potential, as well as medicinal and pharmaceutical uses. The plant has been reported for various uses, such as asthma, bronchitis, cancer, colic, common cold, cough, diabetes, dysentery, and jaundice. The fruit has been extensively studied for its biological activities, which include insecticide, antitumor, and antidiabetic effects. Numerous bioactive compounds have been reported in its fruit bodies, such as essential oils, fatty acids, glycosides, alkaloids, and flavonoids. Of these, flavonoids or caffeic acid derivatives are the constituents associated with the inhibition of fungal or bacterial growth, whereas eudesmane sesquiterpenes or sesquiterpene lactones are most active against insects, mites, and nematodes. In this review, the scientific evidence for the biological activity of C. colocynthis against insecticide, cytotoxic, and antidiabetic effects is summarized.